• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL, BRASIL LTDA SJM TISSUE HEART VALVE (UNKNOWN); HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL, BRASIL LTDA SJM TISSUE HEART VALVE (UNKNOWN); HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Device Problems Backflow (1064); Obstruction of Flow (2423)
Patient Problems Mitral Valve Stenosis (1965); Mitral Valve Insufficiency/ Regurgitation (4451)
Event Date 06/11/2021
Event Type  Injury  
Manufacturer Narrative
As reported in a research article, a tissue valve was replaced due to regurgitation and/or stenosis.A more comprehensive assessment could not be performed as the event was non-contemporaneously reported through a literature review and no device was received for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Event Description
The article, " effects of transapical transcatheter mitral valve implantation", was reviewed.This research article is a retrospective single center experience to compare transapical transcatheter mitral valve-in-valve implantation (tamvi) with surgical redo mitral valve replacement (srmvr) in terms of clinical outcomes.Edwards sapien, st.Jude medical tissue valve, on-x, medtronic hancock, sorin bicarbon, c-e perimount magna mitral ease and mosaic tissue valves were associated with the study.The article concluded that the statistical analysis is still not robust enough to make a claim that tamvi is an appropriate alternative.The outcome of the patient appears only to be related to the patient¿s pre-operative sts score.The primary author of the article is ming-chon hsiung, heart center, cheng hsin general hospital, taipei, taiwan.The correspondence author of the article is jeng wei, heart center, cheng hsin general hospital, taipei, taiwan with the corresponding email: jengwei@mac.Com.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SJM TISSUE HEART VALVE (UNKNOWN)
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ST. JUDE MEDICAL, BRASIL LTDA
rua professor jose vieira de mendonça 1301
engenho nogueira - belo horizonte - mg
belo horizonte 31310 -260
BR  31310-260
Manufacturer (Section G)
ST. JUDE MEDICAL, BRASIL LTDA.
rua professor jose vieira de mendonça 1301
engenho nogueira - belo horizonte - mg
belo horizonte 31310 -260
BR   31310-260
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key12249504
MDR Text Key264273126
Report Number3001883144-2021-00111
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeTW
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial
Report Date 07/29/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/29/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received07/07/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age62 YR
-
-